RESUMO
In biochemistry, the absence of a compact, assembly-free pH sensor with high sensitivity and signal-to-noise ratio has been a persistent hurdle in achieving accurate pH measurements in real time, particularly in complex liquid environments. This manuscript introduces what we believe to be a novel solution in the form of a miniaturized pH sensor utilizing an assembly-free ball lens on a tapered multimode optical fiber (TMMF), offering the potential to revolutionize pH sensing in biochemical applications. A multimode optical fiber (MMF) was subjected to tapering processes, leading to the creation of an ultra-thin needle-like structure with a cross-sectional diameter of about 12.5 µm and a taper length of 3 mm. Subsequently, a ball lens possessing a diameter of 20 µm was fabricated at the apex of the taper. The resultant structure was coated utilizing the dip-coating technique, involving a composite mixture of epoxy and pH-sensitive dye, 2',7'-bis(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF), thereby ensconcing the tapered ball lens with dye molecules for pH sensing. This study encompassed the fabrication and evaluation of six distinct fiber structures, incorporating the cleaved endface, the convex lens, and the ball lens structures to compare light focal lengths and propagation intensities. Computational simulations and numerical analyses were conducted to elucidate the encompassing light focal distances across the full array of lens configurations. The efficacy of the proposed pH sensor was subsequently assessed through its deployment within a complex liquid medium spanning a pH spectrum ranging from 6 to 8. Real-time data acquisition was performed with a fast response time of 0.5 seconds. A comparative analysis with a pH sensor predicated upon a single TMMF embedded with the fluorescent dye underscored the substantial signal enhancement achieved by the proposed system twice the fluorescence signal magnitude. The proposed assembly-free miniaturized pH sensor not only substantiates enhanced signal collection efficiency but also decisively addresses the persistent challenges of poor signal-to-noise ratio encountered within contemporary miniaturized pH probes.
RESUMO
This research focuses on the performance analysis and characterization of a fiber Bragg gratings (FBGs) array, consisting of 10 first-order FBGs inscribed by a femtosecond (FS) laser in a highly multimode coreless fiber. The study evaluates the FBG array's ability to function as a distributed thermal sensing (DTS) platform, with the coreless fiber chosen as the sensing element due to its immunity to dopant migration at high temperatures. The design of a large cascaded first-order FBG array effectively eliminates unwanted harmonic peaks across a wide spectrum range. In contrast, higher-order FBGs introduce limitations due to the overlapping of Bragg peaks with harmonics. The FBG array's performance is evaluated by measuring the reflection spectrum of each grating at different temperatures, showing a high temperature sensitivity of 15.05 pm/°C at a Bragg wavelength of 1606.3â nm, with a linear response in the temperature range of 24 - 1100 °C. The FBG array was designed for a spatial resolution of 5 mm. A mode scrambler in the sensing network is employed, which suppresses multimodal interference, characterizes FBG peak visibility, and stabilizes the interference spectrum. The stability of the FBG array is also assessed over 24 hrs at 1100 °C, and it is observed to be stable during thermal treatment. Heat treatment at 1100°C improves the signal to noise ratio of the FBG array, demonstrating the robustness and suitability of the proposed FBG array on highly multimode coreless fiber as a potential sensing platform for DTS applications in harsh environmental conditions, overcoming the issues of dopant migration presented by dopes silica optical fibers at high temperatures.
RESUMO
This Letter reports the performance of femtosecond (fs) laser-written distributed fiber Bragg gratings (FBGs) under high-temperature conditions up to 1600°C and explores the impact of rapid heat treatment on signal-to-noise ratio (SNR) enhancement. FBGs are essential for reliable optical sensing in extreme temperature environments. Comprehensive tests demonstrate the remarkable performance and resilience of FBGs at temperatures up to 1600°C, confirming their suitability for deployment in such conditions. The study also reveals significant fringe visibility improvements of up to â¼10â dB on a 1-m-long sapphire optical fiber through rapid heat treatment, representing a first-time achievement to the best of our knowledge. These enhancements are vital for improving the SNR and overall performance of optical fiber systems in extreme temperatures. Furthermore, the research attains long-term stability for the cascaded FBGs over a 24-hr period at 1600°C. This research expands our understanding of the FBG behavior in high-temperature environments and opens avenues for developing robust optical fiber systems for energy, aerospace, oil and gas, and high-temperature distributed sensing applications.
RESUMO
This Letter reports an innovative technique for fabricating large-scale, highly cascaded first-order sapphire optical fiber Bragg gratings (FBGs) using a femtosecond laser-assisted point-by-point inscription method. For the first time, to the best of our knowledge, this study successfully demonstrates a distributed array of 10 FBGs within highly multimode sapphire crystal fiber, made possible by employing a high-power laser technique to generate larger reflectors with a Gaussian intensity profile. These first-order FBGs offer advantages such as enhanced reflectivity, shorter fabrication time, and simplified spectral characteristics, making them easier to interpret compared with high-order FBGs. The FBGs' resilience and effectiveness are analyzed by subjecting them to temperature tests, proving their capacity for accurate temperature monitoring up to 1500°C-a testament to their suitability for harsh environments. This novel approach broadens the scope for sensing and communication applications in sapphire fibers, particularly under challenging conditions. The novelty of our work lies in successfully overcoming the limitations of previous designs by integrating a cascade of 10 FBGs in sapphire fibers, thereby enhancing multiplexing capabilities, minimizing overlapping of FBG peaks, and ensuring reliable temperature monitoring in industries and applications with thermal gradients.
RESUMO
This research reports an advancement in splicing silica glass fiber to sapphire single-crystal optical fiber (SCF) using a specialized glass processing device, including data that demonstrate the thermal stability of the splice to 1000°C. A filament heating process was used to produce a robust splice between the dissimilar fibers. A femtosecond laser is used to inscribe a fiber Bragg gratings sensor into the SCF to measure the high-temperature capabilities and signal attenuation characteristics of the splice joint. The experimental results demonstrate that the proposed splicing method produces a splice joint that is robust, stable, repeatable, and withstands temperatures up to 1000°C with a low attenuation of 0.5 dB. The proposed method allows placement of SCF-based sensors in the extreme environments encountered in various engineering fields, such as nuclear, chemical, aviation, and metals manufacturing, to enable improvements in process monitoring, product quality, and production efficiency.
RESUMO
This Letter reports a miniature 7-in-1 fiber-optic Raman probe that eliminates the inelastic background Raman signal from a long-fused silica fiber. Its foremost purpose is to enhance a method for investigating extraordinarily tiny substances and effectively capturing Raman inelastic backscattered signals using optical fibers. We successfully used our home-built fiber taper device to combine seven multimode fibers into a single fiber taper with a probe diameter of approximately 35â µm. By experimentally comparing the traditional bare fiber-based Raman spectroscopy system with the miniaturized tapered fiber-optic Raman sensor using liquid solutions, the novel probe's capability is demonstrated. We observed that the miniaturized probe effectively removed the Raman background signal originating from the optical fiber and confirmed expected outcomes for a series of common Raman spectra.
RESUMO
A highly sensitive strain sensor based on tunable cascaded Fabry-Perot interferometers (FPIs) is proposed and experimentally demonstrated. Cascaded FPIs consist of a sensing FPI and a reference FPI, which effectively generate the Vernier effect (VE). The sensing FPI comprises a hollow core fiber (HCF) segment sandwiched between single-mode fibers (SMFs), and the reference FPI consists of a tunable air reflector, which is constituted by a computer-programable fiber holding block to adjust the desired cavity length. The simulation results predict the dispersion characteristics of modes carried by HCF. The sensor's parameters are designed to correspond to a narrow bandwidth range, i.e., 1530 nm to 1610 nm. The experimental results demonstrate that the proposed sensor exhibits optimum strain sensitivity of 23.9 pm/µÎµ, 17.54 pm/µÎµ, and 14.11 pm/µÎµ cascaded with the reference FPI of 375 µm, 365 µm, and 355 µm in cavity length, which is 13.73, 10.08, and 8.10 times higher than the single sensing FPI with a strain sensitivity of 1.74 pm/µÎµ, respectively. The strain sensitivity of the sensor can be further enhanced by extending the source bandwidth. The proposed sensor exhibits ultra-low temperature sensitivity of 0.49 pm/°C for a temperature range of 25 °C to 135 °C, providing good isolation for eliminating temperature-strain cross-talk. The sensor is robust, cost-effective, easy to manufacture, repeatable, and shows a highly linear and stable response for strain sensing. Based on the sensor's performance, it may be a good candidate for high-resolution strain sensing.
RESUMO
Alpha galactosidase (a-Gal) is an acidic hydrolase that plays a critical role in hydrolyzing the terminal alpha-galactoyl moiety from glycolipids and glycoproteins. There are over a hundred mutations reported for the GLA gene that encodes a-Gal that result in reduced protein synthesis, protein instability, and reduction in function. The deficiencies of a-Gal can cause Fabry disease, a rare lysosomal storage disorder (LSD) caused by the failure to catabolize alpha-d-galactoyl glycolipid moieties. The current standard of care for Fabry disease is enzyme replacement therapy (ERT) where the purified recombinant form of human a-Gal is given to patients. The manufacture of a-Gal is currently performed utilizing traditional large-scale chromatography processes. Developing an affinity resin for the purification of a-Gal would reduce the complexity of the manufacturing process, reduce costs, and potentially produce a higher quality a-Gal. After the evaluation of many small molecules, a commercially available small molecule biomimetic, N-5-Carboxypentyl-1-deoxygalactonojirimycin (N5C-DGJ), was utilized for the development of a novel small molecule biomimetic affinity resin for a-Gal. Affinity purified a-Gal demonstrated a purity greater than 90%, exhibited expected thermal stability and specific activity. Complementing this affinity purification is the development of an elution buffer system that confers an increased thermal stability to a-Gal. The N5C-DGJ affinity resin tolerated sodium hydroxide sanitization with no loss of binding capacity, making it amenable to large scale purification processes and potential use in manufacturing. This novel method for purifying the challenging a-Gal enzyme can be extended to other enzyme replacement therapies.
Assuntos
Cromatografia de Afinidade/métodos , Clonagem Molecular/métodos , Galactose/química , Imino Piranoses/química , Animais , Células CHO , Cricetulus , Estabilidade Enzimática , Expressão Gênica , Vetores Genéticos/química , Vetores Genéticos/metabolismo , Humanos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , alfa-Galactosidase/genética , alfa-Galactosidase/metabolismoRESUMO
The cation-independent mannose-6-phosphate receptor (CI-M6PR, aka insulin-like growth factor II receptor or IGFIIR) is a membrane protein that plays a central role in the trafficking of lysosomal acid hydrolases into lysosomes via mannose-6-phosphate (M6P) binding domains. In order to maintain cellular metabolic/catabolic homeostasis, newly synthesized lysosomal acid hydrolases are required to bind to M6PR for transit. Acid hydrolases secreted by cells can also be internalized via M6PR residing on the cell membrane and are transported to the lysosomes, a feature that enables enzyme replacement therapy for the treatment of several lysosomal storage disorders. Therefore, a thorough characterization of this receptor is critical to the development of lysosomal enzyme-based therapeutics that utilize M6PR for drug delivery to the lysosome. However, the extracellular domain (ECD) of M6PR is highly complex, containing 15-mannose receptor homology (MRH) domains. In addition, homodimerization of the receptor can occur at the membrane, making its characterization challenging. In this study, a novel human M6PR (hM6PR)-overexpressing cell line originally established for hM6PR cellular uptake assay was utilized for production of hM6PR-ECD, and a novel small molecule biomimetic (aminophenyl-M6P) affinity resin was developed for the purification of M6PR-ECD. The affinity-purified hM6PR-ECD was monomeric, contained 14 intact MRH domains (1-14) and a partial MRH domain 15, and was successfully employed in ELISA-based and surface plasmon resonance-based binding assays to demonstrate its ligand-binding functionality, making it suitable for the evaluation of biotherapeutics that utilize M6PR for cellular internalization.
Assuntos
Aminofenóis/química , Materiais Biomiméticos/química , Membrana Celular/enzimologia , Manosefosfatos/química , Receptor IGF Tipo 2/isolamento & purificação , Sequência de Aminoácidos , Aminofenóis/metabolismo , Materiais Biomiméticos/metabolismo , Linhagem Celular Tumoral , Membrana Celular/química , Cromatografia de Afinidade , Ensaios Enzimáticos , Ensaio de Imunoadsorção Enzimática , Fibroblastos/química , Fibroblastos/enzimologia , Expressão Gênica , Humanos , Cinética , Manosefosfatos/metabolismo , Domínios Proteicos , Receptor IGF Tipo 2/genética , Receptor IGF Tipo 2/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Alinhamento de Sequência , Ressonância de Plasmônio de SuperfícieRESUMO
Mucopolysaccharidosis III B (MPS III-B) is a rare lysosomal storage disorder caused by deficiencies in Alpha-N-acetylglucosaminidase (NAGLU) for which there is currently no cure, and present treatment is largely supportive. Understanding the structure of NAGLU may allow for identification of novel therapeutic targets for MPS III-B. Here we describe the first crystal structure of human NAGLU, determined to a resolution of 2.3â¯Å. The crystal structure reveals a novel homotrimeric configuration, maintained primarily by hydrophobic and electrostatic interactions via domain II of three contiguous domains from the N- to C-terminus. The active site cleft is located between domains II and III. Catalytic glutamate residues, E316 and E446, are located at the top of the (α/ß)8 barrel structure in domain II. We utilized the three-dimensional structure of NAGLU to map several MPS III-B mutations, and hypothesize their functional consequences. Revealing atomic level structural information about this critical lysosomal enzyme paves the way for the design of novel therapeutics to target the underlying causes of MPS III-B.
Assuntos
Acetilglucosamina/química , Acetilglucosaminidase/química , Acetilglucosamina/metabolismo , Acetilglucosaminidase/genética , Acetilglucosaminidase/metabolismo , Motivos de Aminoácidos , Domínio Catalítico , Linhagem Celular Tumoral , Clonagem Molecular , Cristalografia por Raios X , Fibroblastos/citologia , Fibroblastos/metabolismo , Expressão Gênica , Vetores Genéticos/química , Vetores Genéticos/metabolismo , Humanos , Interações Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Mucopolissacaridose III/enzimologia , Mucopolissacaridose III/genética , Mucopolissacaridose III/patologia , Mutação , Ligação Proteica , Conformação Proteica em alfa-Hélice , Conformação Proteica em Folha beta , Domínios e Motivos de Interação entre Proteínas , Multimerização Proteica , Estrutura Terciária de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Eletricidade Estática , Homologia Estrutural de Proteína , Especificidade por SubstratoRESUMO
Follistatin (FS) is an important regulatory protein, a natural antagonist for transforming growth factor-ß family members activin and myostatin. The diverse biologic roles of the activin and myostatin signaling pathways make FS a promising therapeutic target for treating human diseases exhibiting inflammation, fibrosis, and muscle disorders, such as Duchenne muscular dystrophy. However, rapid heparin-mediated hepatic clearance of FS limits its therapeutic potential. We targeted the heparin-binding loop of FS for site-directed mutagenesis to improve clearance parameters. By generating a series of FS variants with one, two, or three negative amino acid substitutions, we demonstrated a direct and proportional relationship between the degree of heparin-binding affinity in vitro and the exposure in vivo. The triple mutation K(76,81,82)E abolished heparin-binding affinity, resulting in â¼20-fold improved in vivo exposure. This triple mutant retains full functional activity and an antibody-like pharmacokinetic profile, and shows a superior developability profile in physical stability and cell productivity compared with FS variants, which substitute the entire heparin-binding loop with alternative sequences. Our surgical approach to mutagenesis should also reduce the immunogenicity risk. To further lower this risk, we introduced a novel glycosylation site into the heparin-binding loop. This hyperglycosylated variant showed a 10-fold improved exposure and decreased clearance in mice compared with an IgG1 Fc fusion protein containing the native FS sequence. Collectively, our data highlight the importance of improving pharmacokinetic properties by manipulating heparin-binding affinity and glycosylation content and provide a valuable guideline to design desirable therapeutic FS molecules.
Assuntos
Folistatina/genética , Folistatina/farmacocinética , Engenharia de Proteínas , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacocinética , Motivos de Aminoácidos , Sequência de Aminoácidos , Animais , Feminino , Folistatina/metabolismo , Folistatina/uso terapêutico , Glicosilação , Heparina/metabolismo , Humanos , Camundongos , Mutação , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/uso terapêutico , Distribuição TecidualRESUMO
The microstructures and mechanical properties of equiatomic CoCrFeMnNi high-entropy alloys (HEAs) treated with various processing parameters of laser surface heat treatment are studied in this paper. The typical inverse gradient-grained structure, which is composed of a hard central layer and a soft surface layer, can be obtained by laser surface heat treatment. A much narrower gradient layer leads to the highest yield strength by sacrificing ductility when the surface temperature of the laser-irradiated region remains at ~850 °C, whereas the fully recrystallized microstructure, which exists from the top surface layer to the ~1.05 mm depth layer, increases the ductility but decreases the yield strength as the maximum heating temperature rises to ~1050 °C. Significantly, the superior strength-ductility combination can be acquired by controlling the surface temperature of a laser-irradiated surface at ~1000 °C with a scanning speed of ~4 mm/s due to the effect of hetero-deformation-induced strengthening and hardening, as well as the enhanced interaction between dislocation and nanotwins by the hierarchical nanotwins. Therefore, retaining the partial recrystallized microstructure with a relatively high microhardness in the central layer, promoting the generation of hierarchical nanotwins, and increasing the volume proportion of gradient layer can effectively facilitate the inverse gradient-grained CoCrFeMnNi HEAs to exhibit a desirable strength-ductility synergy.
RESUMO
This study reports for the first time, to the best of our knowledge, a real-time detection of ultralow-concentration chemical gases using fiber-optic technology, combining a miniaturized Fabry-Perot interferometer (FPI) with metal-organic frameworks (MOFs). The sensor consists of a short and thick-walled silica capillary segment spliced to a lead-in single-mode fiber (SMF), housing a tiny single crystal of HKUST-1 MOF, imparting chemoselectivity features. Ethanol and benzene gases were tested, resulting in a shift in the FPI interference signal. The sensor demonstrated high sensitivity, detecting ethanol gas concentrations (EGCs) with a sensitivity of 0.428 nm/ppm between 24.9 and 40.11 ppm and benzene gas concentrations (BGCs) with a sensitivity of 0.15 nm/ppm between 99 and 124 ppm. The selectivity study involved a combination of three ultralow concentrations of ethanol, benzene, and toluene gases, revealing an enhancement factor of 436% for benzene and 140% for toluene, attributed to the improved miscibility of these conjugated ring molecules with the alkane chains of the ethanol-modified HKUST-1. Experimental tests confirmed the sensor's viability, demonstrating significantly improved response time and spectral characteristics through crystal polishing, indicating its potential for quantifying and detecting chemical gases at ultralow concentrations. This technology may prevent energy resource losses, and the sensor's small size and robust construction make it applicable in confined and hazardous locations.
RESUMO
Identifying peripheral biomarkers is an important noninvasive diagnosis method for coronary artery disease (CAD) which has aroused the strong interest of researchers. Cuproptosis, a newly reported kind of programmed cell death, is closely related to mitochondrial respiration, adenosine triphosphate (ATP) production, and the TCA cycle. Currently, no studies have been published about the effects of cuproptosis-related genes (CRGs) on diagnosing CAD. To screen marker genes for CAD from CRGs, we downloaded the whole blood cell gene expression profile of CAD patients and normal samples, i.e., the GSE20680 dataset, from the GEO database. By differential expression analysis, we obtained 10 differentially expressed CRGs (DE-CRGs), which were associated with copper ion response, immune response, and material metabolism. Based on the 10 DE-CRGs, we furtherly performed LASSO analysis and SVM-RFE analysis and identified 5 DE-CRGs as marker genes, including F5, MT4, RNF7, S100A12, and SORD, which had an excellent diagnostic performance. Moreover, the expression of the marker genes was validated in the GSE20681 and GSE42148 datasets, and consistent results were obtained. In mechanism, we conducted gene set enrichment analyses (GSEA) based on the marker genes, and the results implied that they might participate in the regulation of immune response. Therefore, we calculated the relative contents of 22 kinds of immune cells in CAD and normal samples using the CIBERSORT algorithm, followed by differential analysis and correlation analysis of the immune microenvironment, and found that regulatory T cell (Treg) significantly decreased and was negatively correlated with marker gene S100A12. To further reveal the regulation mechanisms, a lncRNA-miRNA-mRNA ceRNA network based on the marker genes was established. Finally, 13 potential therapeutic drugs targeting 2 marker genes (S100A12 and F5) were identified using the Drug Gene Interaction Database (DGIdb). In summary, our findings indicated that some CRGs may be diagnostic biomarkers and treatment targets for CAD and provided new ideas for further scientific research.
Assuntos
Apoptose , Doença da Artéria Coronariana , MicroRNAs , Humanos , Trifosfato de Adenosina , Biomarcadores , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/genética , Proteína S100A12 , CobreRESUMO
Background: Cuproptosis, a newly reported type of programmed cell death, takes part in the regulation of tumor progression, treatment response, and prognosis. But the specific effect of cuproptosis-related genes (CRGs) on glioblastoma (GBM) is still unclear. Methods: The transcriptome data and corresponding clinical data of GBM samples were downloaded from the TCGA and GEO databases. R software and R packages were used to perform statistical analysis, consensus cluster analysis, survival analysis, Cox regression analysis, Lasso regression analysis, and tumor microenvironment analysis. The mRNA and protein expression levels of model-related genes were detected by RT-qPCR and Western blot assays, respectively. Results: The expression profile of CRGs in 209 GBM samples from two separate datasets was obtained. Two cuproptosis subtypes, CRGcluster A and CRGcluster B, were identified by consensus cluster analysis. There were apparent differences in prognosis, tumor microenvironment, and immune checkpoint expression levels between the two subtypes, and there were 79 prognostic differentially expressed genes (DEGs). According to the prognostic DEGs, two gene subtypes, geneCluster A and geneCluster B, were identified, and a prognostic risk score model was constructed and validated. This model consists of five prognostic DEGs, including PDIA4, DUSP6, PTPRN, PILRB, and CBLN1. Ultimately, to improve the applicability of the model, a nomogram was established. Patients with GBM in the low-risk cluster have a higher mutation burden and predict a longer OS than in the high-risk group. Moreover, the risk score was related to drug sensitivity and negatively correlated with the CSC index. Conclusion: We successfully constructed a cuproptosis-related prognostic model, which can independently predict the prognosis of GBM patients. These results further complement the understanding of cuproptosis and provide new theoretical support for developing a more effective treatment strategy.
Assuntos
Glioblastoma , Humanos , Prognóstico , Nomogramas , Apoptose , Western Blotting , Microambiente TumoralRESUMO
Antibody-dependent cellular cytotoxicity (ADCC) is the primary mechanism of actions for several marketed therapeutic antibodies (mAbs) and for many more in clinical trials. The ADCC efficacy is highly dependent on the ability of therapeutic mAbs to recruit effector cells such as natural killer cells, which induce the apoptosis of targeted cells. The recruitment of effector cells by mAbs is negatively affected by fucose modification of N-Glycans on the Fc; thus, utilization of afucosylated mAbs has been a trend for enhanced ADCC therapeutics. Most of afucosylated mAbs in clinical or commercial manufacturing were produced from Fut8-/- Chinese hamster ovary cells (CHO) host cells, generally generating low yields compared to wildtype CHO host. This study details the generation and characterization of two engineered CHOZN® cell lines, in which the enzyme involved in guanosine diphosphate (GDP)-fucose synthesis, GDP mannose-4,6-dehydratase (Gmds) and GDP-L-fucose synthase (FX), was knocked out. The top host cell lines for each of the knockouts, FX-/- and Gmds-/-, were selected based on growth robustness, bulk MSX selection tolerance, production titer, fucosylation level, and cell stability. We tested the production of two proprietary IgG1 mAbs in the engineered host cells, and found that the titers were comparable to CHOZN® cells. The mAbs generated from either KO cell line exhibited loss of fucose modification, leading to significantly boosted FcγRIIIa binding and ADCC effects. Our data demonstrated that both FX-/- and Gmds-/- host cells could replace Fut8-/- CHO cells for clinical manufacturing of antibody therapeutics.
Assuntos
Anticorpos Monoclonais/biossíntese , Carboidratos Epimerases/antagonistas & inibidores , Fucose/metabolismo , Guanosina Difosfato/metabolismo , Hidroliases/antagonistas & inibidores , Cetona Oxirredutases/antagonistas & inibidores , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Citotoxicidade Celular Dependente de Anticorpos , Sequência de Bases , Células CHO , Sistemas CRISPR-Cas , Carboidratos Epimerases/genética , Carboidratos Epimerases/metabolismo , Cricetinae , Cricetulus , Glicosilação , Humanos , Hidroliases/genética , Hidroliases/metabolismo , Imunoglobulina G/imunologia , Cetona Oxirredutases/genética , Cetona Oxirredutases/metabolismo , Receptores de IgG/metabolismoRESUMO
BACKGROUND: Vascular endothelial growth factor has been found to accelerate compensatory lung growth after left pneumonectomy in mice. The aim of this study was to determine the natural history and the effects of vascular endothelial growth factor on compensatory lung growth in a large animal model. METHODS: To determine the natural history of compensatory lung growth, female Yorkshire piglets underwent a left pneumonectomy on days of life 10-11. Tissue harvest and volume measurement of the right lung were performed at baseline (nâ¯=â¯5) and on postoperative days 7 (nâ¯=â¯5), 14 (nâ¯=â¯4), and 21 (nâ¯=â¯5). For pharmacokinetic studies, vascular endothelial growth factor was infused via a central venous catheter, with plasma vascular endothelial growth factor levels measured at various time points. To test the effect of vascular endothelial growth factor on compensatory lung growth, 26 female Yorkshire piglets underwent a left pneumonectomy followed by daily infusion of vascular endothelial growth factor at 200 µg/kg or isovolumetric 0.9% NaCl (saline control). Lungs were harvested on postoperative day 7 for volume measurement and morphometric analyses. RESULTS: Compared with baseline, right lung volume after left pneumonectomy increased by factors of 2.1 ± 0.6, 3.3 ± 0.6, and 3.6 ± 0.4 on postoperative days 7, 14, and 21, respectively. The half-life of VEGF ranged from 89 to 144 minutes. Lesser doses of vascular endothelial growth factor resulted in better tolerance, volume of distribution, and clearance. Compared with the control group, piglets treated with vascular endothelial growth factor had greater lung volume (P < 0.0001), alveolar volume (Pâ¯=â¯0.001), septal surface area (Pâ¯=â¯0.007) and total alveolar count (Pâ¯=â¯0.01). CONCLUSION: Vascular endothelial growth factor enhanced alveolar growth in neonatal piglets after unilateral pneumonectomy.